🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis

Recruitingn/aAges 18 Years - anyAllPapworth Hospital NHS Foundation Trust
NCT07289100 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn about new sensors that measure changes in the body that happen during a chest infection, such as breathing rate and heart rate. This study will be with adults who have either cystic fibrosis or bronchiectasis who start treatment with intravenous antibiotics (usually for around 2 weeks). The main question it aims to answer is the change in sensor measure (such as heart rate) between the start and end of treatment for a chest infection. No follow up visits are required for this study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * ≥ 18 years old * Diagnosis of CF based on genetic testing and /or sweat chloride levels or CT confirmed diagnosis of non-CF bronchiectasis * Under the care of Royal Papworth Hospital * Starting IV antibiotics for treatment of APE as defined by the Hill Criteria ² Exclusion Criteria: * Patients unable to provide written informed consent * Lung transplant recipients or on lung transplant waiting list * Use of long-term oxygen therapy (LTOT) or non-invasive ventilation to manage respiratory failure * Patients unwilling to consent to their link anonymised data from home monitoring being used for research * Considered unsuitable for home monitoring in the opinion of the investigator * Patients being admitted for elective antibiotic treatment (i.e. not being admitted for acute APE treatment)
💊

What it tests

  • Non-Interventional Study
📍

Where

1 site
Royal Papworth Hospital NHS Foundation Trust
Cambridge, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy